CD45RC(high)CD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization

Mamoru Watanabe, Yasuo Hosoda, Susumu Okamoto, Motomi Yamazaki, Nagamu Inoue, Yoshitaka Ueno, Yasushi Iwao, Hiromasa Ishii, Noriaki Watanabe, Yoshiki Hamada, Takaya Yamada, Tatsuo Suzuki, Toshifumi Hibi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

To clarify the role of CD4+ intestinal mucosal lymphocytes in chronic intestinal inflammation, we developed a new rat colitis model by immunization with 2,4,6-trinitrobenzenesulfonic acid (TNB) in an emulsion with an adjuvant followed by transrectal administration of a low dose of TNB. Moreover, we assessed the therapeutic effect of anti-CD4 monoclonal antibody (mAb) on this model. In concert with the development of serum anti-TNB Abs, transmural and segmental colitis that mimics some characteristics of human Crohn's disease was induced in the immunized rats. Immunohistochemical analysis showed the increase of infiltrating lamina propria CD4+ T cells. Flow-cytometric analysis of isolated cells from inflamed mucosa revealed that CD45RC(high)CD4+ T cells were significantly increased. Interestingly, intraperitoneal administration of anti-CD4 mAbs could suppress severe inflammation in the model with decrease of anti-TNB Ab titer. After the treatment with anti-CD4 mAbs, CD45RC(high)CD4+ T cells in the lamina propria and interferon-γ mRNA expression in the colonic lamina propria CD4+ T cells were decreased. These results indicated that Th1 CD4+ intestinal mucosal T cells have a role in the progress of inflamed lesions in chronic enteritis. They implicate that a therapy targeting mucosal T cells expressing CD4 may be feasible in the treatment of human Crohn's disease.

Original languageEnglish
Pages (from-to)46-55
Number of pages10
JournalClinical Immunology and Immunopathology
Volume88
Issue number1
DOIs
Publication statusPublished - 1998 Jul

Fingerprint

Trinitrobenzenesulfonic Acid
Colitis
Immunization
Mucous Membrane
Lymphocytes
T-Lymphocytes
Crohn Disease
Inflammation
Enteritis
Therapeutic Uses
Emulsions
Interferons
Therapeutics
Monoclonal Antibodies
Messenger RNA
Serum

Keywords

  • Animal model
  • CD4
  • Crohn's disease
  • Th1
  • Trinitrobenzenesulfonic acid

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

CD45RC(high)CD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization. / Watanabe, Mamoru; Hosoda, Yasuo; Okamoto, Susumu; Yamazaki, Motomi; Inoue, Nagamu; Ueno, Yoshitaka; Iwao, Yasushi; Ishii, Hiromasa; Watanabe, Noriaki; Hamada, Yoshiki; Yamada, Takaya; Suzuki, Tatsuo; Hibi, Toshifumi.

In: Clinical Immunology and Immunopathology, Vol. 88, No. 1, 07.1998, p. 46-55.

Research output: Contribution to journalArticle

Watanabe, Mamoru ; Hosoda, Yasuo ; Okamoto, Susumu ; Yamazaki, Motomi ; Inoue, Nagamu ; Ueno, Yoshitaka ; Iwao, Yasushi ; Ishii, Hiromasa ; Watanabe, Noriaki ; Hamada, Yoshiki ; Yamada, Takaya ; Suzuki, Tatsuo ; Hibi, Toshifumi. / CD45RC(high)CD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization. In: Clinical Immunology and Immunopathology. 1998 ; Vol. 88, No. 1. pp. 46-55.
@article{cc7cf3e20b244ee088fdbc52168f3463,
title = "CD45RC(high)CD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization",
abstract = "To clarify the role of CD4+ intestinal mucosal lymphocytes in chronic intestinal inflammation, we developed a new rat colitis model by immunization with 2,4,6-trinitrobenzenesulfonic acid (TNB) in an emulsion with an adjuvant followed by transrectal administration of a low dose of TNB. Moreover, we assessed the therapeutic effect of anti-CD4 monoclonal antibody (mAb) on this model. In concert with the development of serum anti-TNB Abs, transmural and segmental colitis that mimics some characteristics of human Crohn's disease was induced in the immunized rats. Immunohistochemical analysis showed the increase of infiltrating lamina propria CD4+ T cells. Flow-cytometric analysis of isolated cells from inflamed mucosa revealed that CD45RC(high)CD4+ T cells were significantly increased. Interestingly, intraperitoneal administration of anti-CD4 mAbs could suppress severe inflammation in the model with decrease of anti-TNB Ab titer. After the treatment with anti-CD4 mAbs, CD45RC(high)CD4+ T cells in the lamina propria and interferon-γ mRNA expression in the colonic lamina propria CD4+ T cells were decreased. These results indicated that Th1 CD4+ intestinal mucosal T cells have a role in the progress of inflamed lesions in chronic enteritis. They implicate that a therapy targeting mucosal T cells expressing CD4 may be feasible in the treatment of human Crohn's disease.",
keywords = "Animal model, CD4, Crohn's disease, Th1, Trinitrobenzenesulfonic acid",
author = "Mamoru Watanabe and Yasuo Hosoda and Susumu Okamoto and Motomi Yamazaki and Nagamu Inoue and Yoshitaka Ueno and Yasushi Iwao and Hiromasa Ishii and Noriaki Watanabe and Yoshiki Hamada and Takaya Yamada and Tatsuo Suzuki and Toshifumi Hibi",
year = "1998",
month = "7",
doi = "10.1006/clin.1997.4508",
language = "English",
volume = "88",
pages = "46--55",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - CD45RC(high)CD4+ intestinal mucosal lymphocytes infiltrating in the inflamed colonic mucosa of a novel rat colitis model induced by TNB immunization

AU - Watanabe, Mamoru

AU - Hosoda, Yasuo

AU - Okamoto, Susumu

AU - Yamazaki, Motomi

AU - Inoue, Nagamu

AU - Ueno, Yoshitaka

AU - Iwao, Yasushi

AU - Ishii, Hiromasa

AU - Watanabe, Noriaki

AU - Hamada, Yoshiki

AU - Yamada, Takaya

AU - Suzuki, Tatsuo

AU - Hibi, Toshifumi

PY - 1998/7

Y1 - 1998/7

N2 - To clarify the role of CD4+ intestinal mucosal lymphocytes in chronic intestinal inflammation, we developed a new rat colitis model by immunization with 2,4,6-trinitrobenzenesulfonic acid (TNB) in an emulsion with an adjuvant followed by transrectal administration of a low dose of TNB. Moreover, we assessed the therapeutic effect of anti-CD4 monoclonal antibody (mAb) on this model. In concert with the development of serum anti-TNB Abs, transmural and segmental colitis that mimics some characteristics of human Crohn's disease was induced in the immunized rats. Immunohistochemical analysis showed the increase of infiltrating lamina propria CD4+ T cells. Flow-cytometric analysis of isolated cells from inflamed mucosa revealed that CD45RC(high)CD4+ T cells were significantly increased. Interestingly, intraperitoneal administration of anti-CD4 mAbs could suppress severe inflammation in the model with decrease of anti-TNB Ab titer. After the treatment with anti-CD4 mAbs, CD45RC(high)CD4+ T cells in the lamina propria and interferon-γ mRNA expression in the colonic lamina propria CD4+ T cells were decreased. These results indicated that Th1 CD4+ intestinal mucosal T cells have a role in the progress of inflamed lesions in chronic enteritis. They implicate that a therapy targeting mucosal T cells expressing CD4 may be feasible in the treatment of human Crohn's disease.

AB - To clarify the role of CD4+ intestinal mucosal lymphocytes in chronic intestinal inflammation, we developed a new rat colitis model by immunization with 2,4,6-trinitrobenzenesulfonic acid (TNB) in an emulsion with an adjuvant followed by transrectal administration of a low dose of TNB. Moreover, we assessed the therapeutic effect of anti-CD4 monoclonal antibody (mAb) on this model. In concert with the development of serum anti-TNB Abs, transmural and segmental colitis that mimics some characteristics of human Crohn's disease was induced in the immunized rats. Immunohistochemical analysis showed the increase of infiltrating lamina propria CD4+ T cells. Flow-cytometric analysis of isolated cells from inflamed mucosa revealed that CD45RC(high)CD4+ T cells were significantly increased. Interestingly, intraperitoneal administration of anti-CD4 mAbs could suppress severe inflammation in the model with decrease of anti-TNB Ab titer. After the treatment with anti-CD4 mAbs, CD45RC(high)CD4+ T cells in the lamina propria and interferon-γ mRNA expression in the colonic lamina propria CD4+ T cells were decreased. These results indicated that Th1 CD4+ intestinal mucosal T cells have a role in the progress of inflamed lesions in chronic enteritis. They implicate that a therapy targeting mucosal T cells expressing CD4 may be feasible in the treatment of human Crohn's disease.

KW - Animal model

KW - CD4

KW - Crohn's disease

KW - Th1

KW - Trinitrobenzenesulfonic acid

UR - http://www.scopus.com/inward/record.url?scp=0031595502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595502&partnerID=8YFLogxK

U2 - 10.1006/clin.1997.4508

DO - 10.1006/clin.1997.4508

M3 - Article

C2 - 9683549

AN - SCOPUS:0031595502

VL - 88

SP - 46

EP - 55

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -